Presence of circulating prostate cancer cells in African American males adversely affects survival

Urologic Oncology

Volumn 7, Issue 4, 2002, Pages 147-152

  Bianco Jr , Fernando J ^a   Powell, Isaac J ^a   Cher, Michael L ^a   Wood Jr , David P ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Micrometastasis; Progression; Prostate cancer; PSA mRNA; Race; RTPCR

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; BIOPSY; BLOOD; CANCER STAGING; DISEASE FREE SURVIVAL; FOLLOW UP; GENETICS; LYMPHADENECTOMY; MORTALITY; NEGRO; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR; TIME; UNITED STATES; AFRICAN AMERICAN; CANCER RELAPSE; CLINICAL TRIAL; DNA EXTRACTION; EUROPEAN AMERICAN; HISTOPATHOLOGY; SCORING SYSTEM; STATISTICAL ANALYSIS;

BIOPSY; CAUCASOID RACE; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMAN; LYMPH NODE EXCISION; MALE; NEGROID RACE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; UNITED STATES; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS;

EID: 0036633073     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00179-5     Document Type: Article

References (21)

1. Detection of hematogenous micrometastasis in patients with prostate cancer
2. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
3. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen; long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy
4. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy; molecular staging of prostate cancer
5. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer
6. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence
7. Removal of the financial barrier to health care; does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system
8. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting
9. Mortality in prostate cancer
10. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow
11. Identification of bone marrow micrometastases in patients with prostate cancer
12. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival
13. Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens
14. Nonparametric estimation from incomplete observations
15. Regression models and life tables
16. Race and cause specific survival with prostate cancer; influence of clinical stage, Gleason score, age and treatment
17. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease
18. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients; correlation with pathological stage
19. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages
20. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer
21. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma